Sinobioway Medicine Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $439M

  • Investors
  • 1

Sinobioway Medicine General Information

Description

Manufacturer of pharmaceuticals. The company indulges in research and development, production and distribution of trimethyl orthoformate, triethyl orthoformate, cytokine drugs, peptides and other pharmaceuticals.

Contact Information

Website
www.bioway-pku.com
Formerly Known As
Xiamen Peking University Road Bioengineering Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PKU Biopark, Number 80 Jinshang Road
  • Xiamen, Fujian 361009
  • China
+86 0592
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Manufacturing
Corporate Office
  • PKU Biopark, Number 80 Jinshang Road
  • Xiamen, Fujian 361009
  • China
+86 0592

Sinobioway Medicine Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinobioway Medicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 17-May-2022 $439M Completed Generating Revenue
3. Secondary Transaction - Private 01-Aug-2021 Completed Generating Revenue
2. Later Stage VC 29-Feb-2016 Completed Generating Revenue
1. Merger/Acquisition 05-Jan-2015 $474M Completed Generating Revenue
To view Sinobioway Medicine’s complete valuation and funding history, request access »

Sinobioway Medicine Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Sinobioway Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-8207122-B2 Anti-cancer bioactive peptides isolated from crude venom of xinjiang lycosa singoriensis Inactive 31-Jul-2007
US-20100145012-A1 Anti-cancer bioactive peptide Active 31-Jul-2007
EP-2184295-B1 Polypeptides having anticancer activity Inactive 31-Jul-2007
EP-2184295-A4 Polypeptides having anticancer activity Active 31-Jul-2007
EP-2184295-A1 Polypeptides having anticancer activity Active 31-Jul-2007 C07K14/43518
To view Sinobioway Medicine’s complete patent history, request access »

Sinobioway Medicine Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
QS Capital Venture Capital Minority
To view Sinobioway Medicine’s complete investors history, request access »

Ready to get started?

Request a free trial

Sinobioway Medicine FAQs

  • When was Sinobioway Medicine founded?

    Sinobioway Medicine was founded in 1998.

  • Where is Sinobioway Medicine headquartered?

    Sinobioway Medicine is headquartered in Xiamen, China.

  • What industry is Sinobioway Medicine in?

    Sinobioway Medicine’s primary industry is Drug Discovery.

  • Is Sinobioway Medicine a private or public company?

    Sinobioway Medicine is a Private company.

  • What is the current valuation of Sinobioway Medicine?

    The current valuation of Sinobioway Medicine is .

  • What is Sinobioway Medicine’s current revenue?

    The current revenue for Sinobioway Medicine is .

  • How much funding has Sinobioway Medicine raised over time?

    Sinobioway Medicine has raised $439M.

  • Who are Sinobioway Medicine’s investors?

    QS Capital has invested in Sinobioway Medicine.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »